1. Association between NSAID Exposure and Kidney Function Decline in Primary Care Patients
- Author
-
Wilson D. Pace, Gerald Pulver, Amy Barton Pai, L. Miriam Dickinson, Chester H. Fox, Jennifer K. Carroll, and Joseph A. Vassalotti
- Subjects
medicine.medical_specialty ,Primary Health Care ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,030232 urology & nephrology ,Renal function ,Health literacy ,General Medicine ,030204 cardiovascular system & hematology ,Institutional review board ,Kidney ,03 medical and health sciences ,0302 clinical medicine ,Universal precautions ,Internal medicine ,Cohort ,medicine ,Humans ,Observational study ,Medical prescription ,Renal Insufficiency, Chronic ,Brief Communications ,business ,Protected health information ,Glomerular Filtration Rate - Abstract
There are limited data evaluating chronic nonsteroidal anti-inflammatory drug (NSAID) exposure and decline in kidney function in primary care practice where rates of NSAID prescribing are high (1,2). The majority of published observational studies have evaluated the association of prescription NSAID use with AKI using claims data in focused geographic areas outside of the United States (1). It is estimated that >36 million Americans use over-the-counter (OTC) NSAIDs and data suggest that many users, regardless of age, exceed the recommended dose (1,3,4). Education materials for prescription ( e.g ., Food and Drug Administration Medication Guide) and OTC (label) NSAIDs have also been noted to have content that is not aligned with the universal precautions for health literacy. Poor literacy around NSAID education materials has been documented among primary care patients with CKD (5). This study sought to evaluate eGFR changes associated with chronic NSAID exposure in a large, geographically vast, primary care cohort using data from the DARTNet Practice Performance Registry receiving prescription and OTC NSAIDs (6). This project was determined to not require oversight by the University of Michigan Institutional Review Board. This determination was based on the fact that the data set analyzed had no protected health information. Eligible patients were ≥18 years old and had at least two eGFR measurements (between 29 ml/min per 1.73 m2) at least 3 months apart. Baseline was defined as the first qualifying eGFR during the study period of January 1, … more...
- Published
- 2022